TIAA CREF Trust’s Medicines Co MDCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$1.93M Hold
39,457
0.01% 228
2016
Q4
$1.34M Hold
39,457
0.01% 244
2016
Q3
$1.49M Buy
39,457
+11,250
+40% +$424K 0.01% 229
2016
Q2
$949K Buy
28,207
+4,511
+19% +$159K 0.01% 269
2016
Q1
$753K Hold
23,696
0.01% 278
2015
Q4
$885K Hold
23,696
0.01% 256
2015
Q3
$900K Buy
23,696
+4,610
+24% +$162K 0.01% 251
2015
Q2
$546K Hold
19,086
0.01% 283
2015
Q1
$535K Hold
19,086
0.01% 282
2014
Q4
$528K Hold
19,086
0.01% 284
2014
Q3
$426K Buy
19,086
+3,849
+25% +$97.8K 0.01% 287
2014
Q2
$443K Hold
15,237
0.01% 284
2014
Q1
$433K Hold
15,237
0.01% 276
2013
Q4
$588K Hold
15,237
0.01% 261
2013
Q3
$511K Buy
15,237
+487
+3% +$15.5K 0.01% 233
2013
Q2
$454K Buy
+14,750
New +$493K 0.01% 230

Other funds holding MDCO

TIAA CREF Trust's MDCO Position: Q1 2017 in Review

TIAA CREF Trust held its Medicines Co (MDCO) position steady in Q1 2017 at 39,457 shares worth $1.93M. The position accounts for 0.01% of the portfolio, ranked #228.

TIAA CREF Trust first reported a position in MDCO in Q2 2013 and has held it in 16 quarters since. 220 funds tracked by Wall St. Rank hold MDCO as of Q1 2017.

  • TIAA CREF Trust held 39,457 shares of Medicines Co worth $1.93M as of Q1 2017.
  • TIAA CREF Trust left its Medicines Co share count unchanged in Q1 2017.
  • Medicines Co made up 0.01% of TIAA CREF Trust's portfolio in Q1 2017, its #228 holding.
  • TIAA CREF Trust first reported a position in Medicines Co in Q2 2013 and has held it in 16 quarters since.
  • 220 funds tracked by Wall St. Rank held Medicines Co as of Q1 2017.

Based on TIAA CREF Trust's 13F filing for Q1 2017, filed 3 May 2017.